Inventory increased 630.1%
Inventory changed +630.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +630.1% from the comparable as-filed period.
Operating income changed -35.2% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Operating margin changed +21879 basis points from the comparable as-filed period.
Research & development changed +533.5% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Revenue changed +267.6% from the comparable as-filed period.
Selling, general & administrative changed +75.1% from the comparable as-filed period.
Net income changed +16.2% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Cash & equivalents changed +5.0% from the comparable as-filed period. The change ranks at the 7th percentile of 15 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.